Insiders Jazz Pharmaceuticals plc

Equities

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
103.5 ^USD	-1.48%		-3.39%	-15.83%

Jul. 01	Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell Midcap Growth Index	CI
Jul. 01	Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 3000 Growth Index	CI

Jazz Pharmaceuticals plc Announces Catherine Sohn, Pharm.D. Will Not Stand for Re-Election to the Board	May. 31	CI
Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing	May. 07	MT
Jazz Pharmaceuticals Announces Board Changes	Feb. 27	CI
Jazz Pharmaceuticals Names Philip Johnson as Chief Financial Officer	Feb. 21	MT
Jazz Pharmaceuticals plc Appoints Philip Johnson as Executive Vice President, Effective March 1, 2024	Feb. 21	CI
Kim Sablich to Departure as Executive Vice President and General Manager, US of Jazz Pharmaceuticals plc on December 31, 2023	Dec. 15	CI
Jazz Pharmaceuticals President, COO Dan Swisher to Retire; Renee Gala Named Successor	23-09-12	MT
Jazz Pharmaceuticals plc Announces Management Changes	23-09-11	CI
Insider Sell: Jazz Pharmaceuticals	23-08-17	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Insider Sell: Jazz Pharmaceuticals	23-08-15	MT
Oxford Cannabinoid Technologies Hires Chief Medical Officer	23-06-08	MT
Insider Sell: Jazz Pharmaceuticals	22-12-22	MT
Insider Sell: Jazz Pharmaceuticals	22-12-13	MT
Insider Sell: Jazz Pharmaceuticals	22-12-05	MT
Insider Sell: Jazz Pharmaceuticals	22-11-28	MT
Insider Sell: Jazz Pharmaceuticals	22-11-18	MT

No results for this search